Founding offer · lifetime membership for a single £24, exclusive to our first members · closes 20 June Claim your place →
Global Research Partnerships £24 Lifetime Log inCreate free account

Funded Projects › H2020

VOGAS · Screening of Gastric Cancer via Breath volatile organic compounds by Hybrid Sensing Approach

H2020Status: CLOSED1 January 201930 September 2022EU funding €3,781,180Call H2020-SC1-BHC-2018-2020

Gastric cancer has good chances to be cured if diagnosed at an early stage; currently, there is lack of a reliable non-invasive screening tool. Eastern Europe and Latin America are among the geographical areas with high burden of the disease.This project is aiming at developing a non-invasive gastric cancer screening tool by detecting characteristic panels of volatile organic compounds (VOCs). The mechanisms of VOC origin and their composition in gastric cancer patients will be addressed via headspace analysis of cancer tissue, cell-lines, and bacterial flora; VOCs identified during this analysis will be compared to the compounds present in human breath, both via gas chromatography coupled to mass spectrometry (GC-MS).Based on this data, a new type of breath analyser will be developed and validated building upon previously acquired expertise of the consortium members. Specifically, the exhaled breath analyser will combine electronic nose concepts utilizing gold nanoparticles and metal oxide sensors with orthogonal mid-infrared spectroscopic techniques for obtaining multi-dimensional analytical data sets; furthermore, compact pre-concentration schemes will be evaluated. All components will be integrated into several prototypes of portable and optimized devices.The clinical studies will be conducted in parallel in European (Latvia, Ukraine) and Latin American (Colombia, Brazil, Chile) countries with high disease burden. Patients with gastric cancer and individuals with and without precancerous lesions (dysplasia, atrophy, intestinal metaplasia) will be enrolled. The role of confounding factors including H.pylori infection will be addressed.As the main result, we expect to provide the first reliable non-invasive gastric cancer screening device based on exhaled breath analysis concepts for future large-scale implementation. The development of according research competences and international collaborations therefore is the most vital component of this project.

Consortium · 12 organisations

coordinator

TECHNION - ISRAEL INSTITUTE OF TECHNOLOGY

IL · €677,434

participant

JLM INNOVATION GMBH

DE · €425,000

participant

NATIONAL CANCER INSTITUTE STATE NON-PROFIT ENTERPRISE

UA · €197,500

participant

TEKNOLOGIAN TUTKIMUSKESKUS VTT OY

FI · €358,875

participant

UNIVERSITAET ULM

DE · €466,250

participant

HOSPITAL UNIVERSITARIO SAN IGNACIO

CO · €203,735

participant

UPPSALA UNIVERSITET

SE · €253,728

participant

UNIVERSIDAD DE PAMPLONA

CO · €111,055

participant

PONTIFICIA UNIVERSIDAD CATOLICA DE CHILE

CL · €182,069

participant

FUNDACAO ANTONIO PRUDENTE

BR

participant

LATVIJAS UNIVERSITATE

LV · €510,000

participant

UNIVERSITAET INNSBRUCK

AT · €395,535

Research fields

View the official record on CORDIS →

← Find collaborators and more funded projects

Source: CORDIS, Publications Office of the European Union. Global Research Partnerships surfaces open EU research data to help you find collaborators; we are not affiliated with the European Union.